S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
18.46
+1.78
+10.67%
SENS · Senseonics Holdings, Inc.
NYSE MKT LLC - Real Time Price • USD
$7.96
-0.23
(-2.81%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$7.96
$7.96
$8.31
52-WEEK RANGE
$7.96
$4.79
$10.64
What's happening
- SENS is down 2.81% today, trading at $7.96. — Live quote
- Volume today (31,112) is well below its 3-month average of 720,940. (Finnhub fundamentals)
- Reports earnings on 2026-11-10, 19 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $-0.63 actual vs. $-0.64 estimated (+1.1%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 2
Buy 7
Hold 3
Sell 1
Strong sell 0
Aggregate ratings for 2026-10-01 (13 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
SENS
+48.73%
vs S&P 500
+35.95%
1-YEAR RETURN
SENS
-3.07%
vs S&P 500
-17.63%
6-MONTH RETURN
SENS
+21.27%
3-MONTH RETURN
SENS
+63.22%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.63
Est. $-0.64
BEAT +1.1%
2026-04-26 (Q1 2026)
$-0.71
Est. $-0.69
MISS -2.8%
2026-01-26 (Q4 2025)
$-0.47
Est. $-0.44
MISS -6.1%
2025-10-26 (Q3 2025)
$-0.43
Est. $-0.29
MISS -50.6%
Valuation Measures & Ratios
Enterprise Value4$440.1M
Forward P/E5—
PEG Ratio6-0.32
Price / Sales (TTM1)8.84
Price / Book72.63
EV4 / Revenue9.07
EV4 / EBITDA—
Profit Margin-225.34%
Operating Margin-223.22%
Return on Equity (ROE8)-165.83%
Return on Assets (ROA9)-80.16%
Avg Volume (3M)720,940
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $330.9M | $304.7M | $393.5M | $382.7M | $469.5M |
| P/E | -3.21 | -3.78 | -5.45 | -5.24 | -6.07 |
| Price/Sales | 8.08 | 9.31 | 15.58 | 17.37 | 22.98 |
| Price/Book | 3.66 | 8.87 | 5.03 | 4.04 | 13.34 |
| EV/Revenue | 8.35 | 9.51 | 15.61 | 17.54 | 22.76 |
| EV/EBITDA | -3.42 | -4.01 | -5.72 | — | — |
| ROE | -114.12% | -234.81% | -92.45% | -77.09% | -219.90% |
| ROA | -58.29% | -78.38% | -51.65% | -48.59% | -88.75% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short5,370,986
Change from Prior Settlement+6.27%
% of Float—
Days to Cover (Short Ratio)6.34
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 117.8% on the provider's reported measure. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-10-05; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is -225.3%. Finnhub fundamentals ↗
- Trailing 52-week price return is -3.1%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on SENS
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.5M | $11.7M | $8.1M | $6.6M | $6.3M | $4.3M | $4.9M | $5.0M |
| Gross profit | $8.6M | $6.9M | $3.5M | $3.1M | $1.5M | -$4.1M | $298.0K | $335.0K |
| Operating income | -$36.0M | -$31.8M | -$19.6M | -$14.3M | -$13.5M | -$22.8M | -$19.5M | -$18.2M |
| Net income | -$36.7M | -$32.3M | -$19.5M | -$14.5M | -$14.3M | -$24.0M | -$20.3M | -$18.9M |
| EPS (diluted) | $-0.63 | $-0.71 | $-0.43 | $-0.36 | $-0.40 | $-0.77 | $-0.03 | $-0.03 |
| EPS (basic) | $-0.63 | $-0.71 | $-0.43 | $-0.36 | $-0.40 | $-0.77 | $-0.03 | $-0.03 |
| Operating margin | -$248 | -$272 | -$242 | -$215 | -$216 | -$536 | -$401 | -$361 |
| Net margin | -$253 | -$276 | -$241 | -$218 | -$228 | -$562 | -$417 | -$374 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $176.8M | $102.9M | $126.3M | $139.9M | $150.3M | $87.2M | $100.4M | $96.3M |
| Total liabilities | $86.5M | $68.5M | $65.2M | $61.8M | $55.6M | $52.0M | $79.3M | $75.9M |
| Stockholders' equity | $90.3M | $34.3M | $61.0M | $78.2M | $94.7M | $35.2M | -$16.6M | -$17.2M |
| Total current assets | $166.5M | $92.3M | $117.5M | $131.3M | $141.6M | $78.4M | $91.4M | $87.7M |
| Total current liabilities | $24.7M | $26.3M | $24.3M | $21.1M | $14.8M | $11.4M | $38.8M | $35.5M |
| Cash & equivalents | $44.8M | $29.6M | $40.2M | $34.5M | $31.5M | $39.3M | $74.6M | $27.1M |
| Marketable securities (current) | $97.9M | $34.7M | $53.8M | $76.5M | $94.9M | $24.9M | — | $47.4M |
| Accounts receivable | $10.3M | $14.7M | $12.1M | $7.2M | $5.2M | $4.5M | $6.3M | — |
| Inventory | $8.5M | $8.3M | $6.7M | $6.3M | $4.7M | $4.5M | $4.4M | $3.2M |
| Other current assets | — | — | — | — | — | — | — | — |
| Marketable securities (non-current) | — | — | — | — | — | — | — | — |
| Property, plant & equipment | — | — | — | — | — | — | — | $3.4M |
| Intangible assets | — | — | $600.0K | — | — | — | — | — |
| Accounts payable | $4.8M | $3.2M | $4.1M | $5.9M | $2.3M | $2.0M | $3.2M | $2.1M |
| Accrued liabilities | — | — | — | — | — | — | — | — |
| Deferred revenue (current) | — | — | — | — | — | — | — | — |
| Other current liabilities | — | — | — | — | — | — | — | — |
| Long-term debt | $55.8M | $35.9M | $35.6M | $35.3M | $35.2M | $35.0M | $34.7M | $34.4M |
| Other non-current liabilities | — | — | — | — | — | $5.7M | $5.8M | $5.9M |
| Common stock & paid-in capital | $53.0K | $42.0K | $41.0K | $41.0K | $815.0K | $654.0K | $30.0K | $546.0K |
| Retained earnings | -$1.09B | -$1.05B | -$1.02B | -$996.2M | -$976.6M | -$962.1M | -$947.9M | -$932.4M |
| Accumulated other comprehensive income (loss) | -$54.0K | $8.0K | $69.0K | $88.0K | $23.0K | -$3.0K | — | $34.0K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$30.1M | -$32.0M | -$18.0M | -$15.8M | -$9.3M | -$16.1M | -$14.2M | -$14.8M |
| Investing cash flow | -$63.4M | $18.0M | $22.6M | $18.9M | -$69.6M | -$25.3M | $47.7M | $3.3M |
| Financing cash flow | $108.7M | $3.4M | $1.1M | -$134.0K | $71.1M | $6.1M | $14.1M | $3.7M |
| Free cash flow | -$30.4M | -$32.1M | — | — | -$9.4M | -$16.5M | — | — |
| Capital expenditures | $217.0K | $111.0K | — | — | $124.0K | $434.0K | — | — |
| Depreciation & amortization | $548.0K | $545.0K | $382.0K | $376.0K | $370.0K | $384.0K | $766.0K | $196.0K |
| Share-based compensation | $3.6M | $2.3M | $2.6M | $2.8M | $2.9M | $1.8M | $2.1M | $2.4M |
| Change in accounts receivable | -$3.8M | $3.0M | $5.1M | $2.3M | $1.0M | -$1.6M | $3.1M | -$310.0K |
| Change in inventory | -$28.0K | $1.3M | $848.0K | $1.7M | $210.0K | $236.0K | $1.2M | -$400.0K |
| Change in accounts payable | $1.5M | -$870.0K | -$1.8M | $3.6M | $281.0K | -$852.0K | $1.1M | $349.0K |
| Purchases of investments | $94.4M | $4.0M | $0 | $6.3M | $69.5M | $24.9M | $0 | $8.4M |
| Sales/maturities of investments | — | — | — | — | — | — | — | — |
| Debt issued | — | — | — | — | — | — | — | — |
| Tax withholding on stock comp | $1.1M | $150.0K | $563.0K | $0 | $1.2M | — | $622.0K | $0 |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $35.3M | $22.5M | $22.4M | $16.4M | $1.4M |
| Gross profit | $15.8M | $533.0K | $3.1M | $2.7M | -$811.0K |
| Operating income | -$68.3M | -$74.8M | -$75.6M | -$68.6M | -$57.2M |
| Net income | -$69.1M | -$78.6M | -$60.4M | $142.1M | -$302.5M |
| EPS (diluted) | $-1.66 | $-2.50 | $-0.11 | $-0.11 | $-0.72 |
| EPS (basic) | $-1.66 | $-2.50 | $-0.11 | $0.30 | $-0.72 |
| Operating margin | -$194 | -$333 | -$338 | -$419 | -$4.1K |
| Net margin | -$196 | -$350 | -$270 | $867 | -$21.7K |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $126.3M | $100.4M | $138.2M | $177.7M | $198.9M |
| Total liabilities | $65.2M | $79.3M | $64.8M | $142.6M | $384.5M |
| Stockholders' equity | $61.0M | -$16.6M | $35.8M | -$2.6M | -$185.5M |
| Total current assets | $117.5M | $91.4M | $130.0M | $161.2M | $144.4M |
| Total current liabilities | $24.3M | $38.8M | $17.3M | $31.5M | $18.4M |
| Cash & equivalents | $40.2M | $74.6M | $75.7M | $35.8M | $33.5M |
| Marketable securities (current) | $53.8M | — | $33.7M | $108.2M | $96.4M |
| Inventory | $6.7M | $4.4M | $8.8M | $7.3M | $6.3M |
| Other current assets | — | — | — | — | — |
| Marketable securities (non-current) | — | — | — | $12.3M | $51.9M |
| Property, plant & equipment | — | — | $1.2M | $1.1M | $1.3M |
| Intangible assets | $600.0K | — | — | — | — |
| Accounts payable | $4.1M | $3.2M | $4.6M | $419.0K | $1.2M |
| Accrued liabilities | — | — | — | — | — |
| Deferred revenue (current) | — | — | — | — | — |
| Other current liabilities | — | — | — | — | — |
| Long-term debt | $35.6M | $34.7M | $41.2M | $56.4M | $59.8M |
| Other non-current liabilities | — | — | $6.2M | $2.7M | $579.0K |
| Common stock & paid-in capital | $41.0K | $30.0K | $530.0K | $480.0K | $447.0K |
| Retained earnings | -$1.02B | -$947.9M | -$869.3M | -$808.9M | -$951.0M |
| Accumulated other comprehensive income (loss) | $69.0K | — | -$11.0K | -$678.0K | -$212.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$59.1M | -$60.5M | -$70.2M | -$66.3M | -$56.1M |
| Investing cash flow | -$53.4M | $32.8M | $89.7M | $26.9M | -$148.7M |
| Financing cash flow | $78.2M | $26.8M | $20.4M | $41.8M | $220.1M |
| Depreciation & amortization | $1.5M | $1.5M | $1.3M | $985.0K | $1.2M |
| Share-based compensation | $10.2M | $9.2M | $8.7M | $8.6M | $9.0M |
| Change in accounts receivable | $6.8M | $2.7M | $2.2M | $478.0K | -$1.0M |
| Change in inventory | $3.0M | -$696.0K | $1.6M | $989.0K | $1.0M |
| Change in accounts payable | $1.2M | -$1.8M | $2.3M | -$785.0K | -$559.0K |
| Purchases of investments | $100.7M | $58.0M | $68.5M | $104.7M | $154.5M |
| Sales/maturities of investments | — | — | — | — | $6.0M |
| Tax withholding on stock comp | $1.7M | $1.7M | $2.7M | $2.6M | $5.3M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding SENS as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-05-19 to 2026-10-01
Recent transactions
- Insiders have net bought 13,953 shares over the last 182 days, across 1 purchase and 0 sales.
- Most recent: Prince Douglas S (Reporting person) — Grant / award of 815 shares on 2026-10-01.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)13,953 sh(1 txns)
Sales (open market)0 sh(0 txns)
Net Shares+13,953
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Prince Douglas S | Reporting person | Grant / award | 2026-10-01 | 815 |
| ROEDER DOUGLAS A | Reporting person | Grant / award | 2026-10-01 | 1,480 |
| Fiorentino Edward | Reporting person | Grant / award | 2026-10-01 | 1,418 |
| Steven Edelman | Reporting person | Grant / award | 2026-10-01 | 1,292 |
| Kaufman Francine | Chief Medical Officer | Tax withholding | 2026-06-15 | 4,010 |
| JAIN Mukul | Chief Operating Officer | Tax withholding | 2026-06-15 | 16,194 |
| Sullivan Frederick T. | Chief Financial Officer | Tax withholding | 2026-06-15 | 5,397 |
| Horton Kenneth L | GC & Corp. Development Advisor | Tax withholding | 2026-06-15 | 9,545 |
| HANSEN BRIAN B | Chief Commercial Officer | Tax withholding | 2026-06-15 | 5,420 |
| Goodnow Timothy T | President and CEO | Tax withholding | 2026-06-15 | 32,598 |
| DeFalco Stephen P | Reporting person | Grant / award | 2026-05-20 | 9,852 |
| Larkin Sharon | Reporting person | Grant / award | 2026-05-20 | 9,852 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-01 | Prince Douglas S | Reporting person | Grant / award | 815 | $9.96 |
| 2026-10-01 | ROEDER DOUGLAS A | Reporting person | Grant / award | 1,480 | $9.96 |
| 2026-10-01 | Fiorentino Edward | Reporting person | Grant / award | 1,418 | $9.96 |
| 2026-10-01 | Steven Edelman | Reporting person | Grant / award | 1,292 | $9.96 |
| 2026-08-19 | ROEDER DOUGLAS A | Reporting person | Open market purchase | 13,953 | $8.98 |
| 2026-07-01 | Prince Douglas S | Reporting person | Grant / award | 1,515 | $5.36 |
| 2026-07-01 | ROEDER DOUGLAS A | Reporting person | Grant / award | 2,751 | $5.36 |
| 2026-07-01 | Fiorentino Edward | Reporting person | Grant / award | 2,635 | $5.36 |
| 2026-07-01 | Steven Edelman | Reporting person | Grant / award | 2,402 | $5.36 |
| 2026-06-15 | Kaufman Francine | Chief Medical Officer | Tax withholding | 4,010 | $7.18 |
| 2026-06-15 | JAIN Mukul | Chief Operating Officer | Tax withholding | 16,194 | $7.18 |
| 2026-06-15 | Sullivan Frederick T. | Chief Financial Officer | Tax withholding | 5,397 | $7.18 |
| 2026-06-15 | Horton Kenneth L | GC & Corp. Development Advisor | Tax withholding | 9,545 | $7.18 |
| 2026-06-15 | HANSEN BRIAN B | Chief Commercial Officer | Tax withholding | 5,420 | $7.18 |
| 2026-06-15 | Goodnow Timothy T | President and CEO | Tax withholding | 32,598 | $7.18 |
| 2026-05-20 | DeFalco Stephen P | Reporting person | Grant / award | 9,852 | $0.00 |
| 2026-05-20 | Steven Edelman | Reporting person | Grant / award | 9,852 | $0.00 |
| 2026-05-20 | Fiorentino Edward | Reporting person | Grant / award | 9,852 | $0.00 |
| 2026-05-20 | Larkin Sharon | Reporting person | Grant / award | 9,852 | $0.00 |
| 2026-05-20 | Prince Douglas S | Reporting person | Grant / award | 9,852 | $0.00 |
| 2026-05-20 | ROEDER DOUGLAS A | Reporting person | Grant / award | 9,852 | $0.00 |
| 2026-05-19 | Kaufman Francine | Chief Medical Officer | Grant / award | 63,177 | $0.00 |
| 2026-05-19 | Horton Kenneth L | GC & Corp. Development Advisor | Grant / award | 157,943 | $0.00 |
| 2026-05-19 | JAIN Mukul | Chief Operating Officer | Grant / award | 270,759 | $0.00 |
| 2026-05-19 | Sullivan Frederick T. | Chief Financial Officer | Grant / award | 90,253 | $0.00 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 08:37 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-05 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-10-05 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-10-05 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-10-05 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-08-20 | 4 | 2026-08-19 | View on SEC.gov → |
| 2026-08-06 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-06 | 8-K | 2026-08-06 | View on SEC.gov → |
| 2026-07-02 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-07-02 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-07-02 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-07-02 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-06-17 | 4 | 2026-06-15 | View on SEC.gov → |
Recent news
Headlines about SENS (Senseonics Holdings, Inc.). Links open the publisher — we don’t host full articles.
-
Sensys Gatso receives SEK 36.5m order in Saudi Arabia
www.marketscreener.com · 2026-10-22 -
Sens dump former captain Tkachuk and Panthers 5-1
Global News · 2026-10-22 -
Senseonics Holdings, Inc. Schedules Third Quarter 2026 Earnings Release and Conference Call for November 9, 2026 at 4:30 P.M. Eastern Time
Yahoo · 2026-10-21 -
Barclays sets USD 10 target for Senseonics Holdings stock
AD HOC NEWS · 2026-10-20 -
Sensorion rallies after appointment of chief medical officer
www.marketscreener.com · 2026-10-19 -
Sensorion Announces the Appointment of Peter Weber, MD, MBA, as Chief Medical Officer
Yahoo Finance · 2026-10-19 -
Sensorion recruits a gene therapy pioneer as Chief Medical Officer to advance deaf gene therapy
Idéal Investisseur · 2026-10-19 -
SENS261016P00002500 interactive stock chart | SENS Oct 2026 2.500 put stock
Yahoo Finance Australia · 2026-10-18
No headlines in this category right now — try “All”.